Back to Journals » Drug Design, Development and Therapy » Volume 12

Review

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer

       
Total article views   HTML views PDF downloads Totals
18,308 Dovepress* 13,273+ 1,665 14,938
PubMed Central* 5,035 1,198 6,233
Totals 18,308 2,863 21,171
*Since 21 March 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed and Google Scholar